DDX3X and breast cancer: Moreover, DDX3X expression in breast cancer was found to be increased by hypoxia-inducible factor 1-alpha (HIF-1α), a transcription factor that induces the transcriptional activation of DDX3X via binding to the HIF-responsive element located in the DDX3X promoter.